In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Turkey Regulatory Update: Industry Warns on Euro rate, Political Ambitions Thwarted

This article was originally published in PharmAsia News

Executive Summary

The chairman of the Pharmaceutical Manufacturers Association of Turkey (IEIS) has said that the cost of not updating the Euro exchange rate for the industry has exceeded $6.1 billion, while the ex-president of the SGK, who resigned her post to become an MP candidate for the June elections, has not been nominated. Four drugs have been added to the reimbursement list.



Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts